
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.14 | 3.15315315315 | 4.44 | 4.6908 | 4.09 | 35024 | 4.41638416 | CS |
4 | 0.18 | 4.09090909091 | 4.4 | 4.99 | 4.09 | 43239 | 4.49956693 | CS |
12 | -0.47 | -9.30693069307 | 5.05 | 6.2899 | 4.04 | 56931 | 4.84119196 | CS |
26 | -1.37 | -23.025210084 | 5.95 | 6.83 | 3.85 | 72170 | 4.92873066 | CS |
52 | -3.6 | -44.0097799511 | 8.18 | 10.4 | 3.8181 | 336948 | 6.90574997 | CS |
156 | -54.62 | -92.2635135135 | 59.2 | 102.6 | 3.8181 | 534105 | 28.81757094 | CS |
260 | -192.82 | -97.6798378926 | 197.4 | 356.4 | 3.8181 | 453789 | 53.73721473 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales